Medicine & TechnologyAre you having trouble kicking the habit for good? If so, you may want to consider betting money on yourself. In a new study, researchers have found that smokers who wager money on themselves to quit smoking have better odds of finally quitting smoking.
Have you ever wondered why you have had such a hard time quitting smoking while other people you know simply put them down and never looked back? In a new study, researchers found that the brains of smokers who do manage to quit may actually be "hardwired" for success in kicking the habit.
Just months after the White House announced plans to normalize relations with Cuba, an exciting research partnership is in the works, which just might prolong the lives of those suffering from lung cancer.
In a new study, researchers have found that the seasons appear to influence when certain genes are active in your body, with those that cause inflammation being more active in winter.
After a ban of more than three decades, gay men in the United States may soon be allowed to donate blood, according to new recommendations released today by the U.S. Food and Drug Administration.
Just as the Ebola threat wanes, a new pathogen is reaching epidemic proportions across parts of Africa. To make matters worse, it's resistant to traditional antibiotics.
In a disturbing report published in the Annals of Internal Medicine today, the death of a healthy 53-year-old woman was linked to a dietary supplement, β-methylphenylethylamine, which when combined with exercise, can cause hemorrhagic stroke.
Swedish researchers headed by Jonas Ludvigsson, MD, PhD, of Stockholm's Karolinska Institute, revealed that patients with celiac disease were 2.5 times more likely to be diagnosed with neuropathy. The study, published this week in the journal JAMA Neurology, was conducted among a large group of patients with celiac disease which had been confirmed by biopsy.
Although Ebola has finally been contained in Liberia, there is much to learn from this latest outbreak. Health officials are taking heed of the valuable lessons gained from the successes, and more importantly, the failures, of this most recent epidemic.
A year later and over 4,000 dead, Liberia can finally breathe a sigh of relief as The World Health Organization (WHO) declares the country Ebola free.
"The outbreak of Ebola virus disease in Liberia is over," according to a WHO statement given at the emergency command center in Monrovia, as reported by The New York Times.
But this doesn't mean Africa is in the clear. In fact, if the countries surrounding Liberia are included, the death toll from the past year's outbreak soars to more than 11,000, making the current outbreak five times deadlier that all previous outbreaks combined.
Ten months ago the perfect storm of weak public health policy, poverty, and the Ebola virus transformed Liberia into a bloody battleground. The epicenter of the disaster was the Logan Town clinic, where workers without gloves or running water tried by candlelight to try to save their first patient in the crisis. Now, less than a year later, the Logan Town Clinic and its employees—like the rest of Liberia—is equipped to handle Ebola and any similar disease epidemic.
If you're a smoker in China, you'll be paying about a penny more per puff, now that the Chinese government has decided to hike taxes on cigarettes. In an effort to curb the public's avid consumption, while at the same time raise tax revenue, the government announced Friday they will be increasing taxes on cigarettes from 5% to 11%, beginning May 10.
San Francisco has become the first city in the nation to ban chewing tobacco from its playing fields, including the home to the San Francisco Giants, AT&T Park.
In a new study by the Pew Research Center and the Census Bureau, researchers have discovered that fewer women in the United States are childless in their 40s. The most significant drop was noticed for women who had master's degrees or doctorates. In 1994, 30 percent of the women with higher education were childless, but last year that number had dropped to 22 percent.
The first human trials of an investigational vaccine against West Nile virus have begun. Researchers will evaluate the efficacy of the vaccine in the clinical trials which are taking place at Duke University. Currently there is no approved vaccine for use in humans.